Multiple Myeloma is a
malignant or cancerous condition of the plasma cells of the blood. It is
also called Plasma cell Myeloma. The word Myeloma pertains to the cells
of bone marrow. The bone marrow is a soft substance within the bones
which manufacture all kinds of blood cells. The basic cells are called
stem cells. Some of the stem cells develop into small white cells, also
called as Lymphocytes. The lymphocytes are of two types, B Lymphocytes
and T Lymphocytes. (They are also called B cells and T cells). The B
cells, further grow into Plasma cells, when the foreign substance
(antigen) or bacteria enter the body, the B cells develop into Plasma
cells to form what is called as Immunoglobulin's (antibodies), to
fight against the
antigens or infections. The Immunoglobulin's are denoted as
Ig, which are of five major types: IgG, IgA, IgM, IgD and IgE.
In short, the plasma cells have the capacity to turn into the
Immunoglobulin's (Ig), as a part of the defense mechanism of the body.
These plasma cells when turn cancerous, it is called Multiple Myeloma.
These cancerous plasma cells keep multiplying rapidly and travel in the
blood stream, damaging body tissues. The malignant plasma cells produce
too many (multiple) Immunoglobulin's which are actually not required by
the body. This entire condition is called Multiple Myeloma.
is nothing but the cancer of the plasma cell, an important part of the
immune system that produces immunoglobulin (antibodies) to help fight
infection and disease. Unchecked overgrowth of these cells leads to
multiple tumors and lowered immunity. The tumors invade the hard surface
of the specially the large bone, spreading into the cavities of the
bones. Multiple Myeloma is the second most common blood cancer, after
Non-Hodgkin's Lymphomas. About 13000 new cases of MM are reported every
year in the US. It is relatively more common amongst the Americans
versus their Asian counterpart. It is more common in men, after 60 years
The exact cause for MM is not yet clearly understood. The common factors
influencing the development of MM are genetic tendency, radiation,
chemicals (herbicides, insecticides, petroleum products, heavy metals,
plastics) , and virus.
The clinical symptoms often are vague or no symptoms in the early stage
the presenting symptoms are:
1. Severe lower back pain or rib pain
2. Anemia and lowered immunity leads to weakness and
tendency to frequent infections, as the production of
Immunoglobulin's is disturbed.
Role of Homoeopathy for Multiple Myeloma:
Myeloma being a chronic difficult disease of unknown origin,
largely affecting the vital functions at the constitutional
and immunological level, the homoeopathic approach is, in
turn, constitutional. The treatment is aimed at controlling
the disease process of multiplication of the malignant
cellular overgrowth and hence, trying to keep a check on the
cellular destruction. Also, the medication is aimed at
controlling the spread of the disease. There is no major
study done to evaluate the role of homoeopathy for a series
of cases of MM. However, our brief experience is suggestive
of using homoeopathy as an important supportive measure
during all the stages of Multiple Myeloma. Some research is
likely to throw light on a better defined role of
homoeopathy. In the light of the fact that homoeopathy has
an established role in the treatment of various
immunologically mediated diseases, Multiple Myeloma patients
should not be deprived of the benefits of homoeopathy.
Homoeopathy is safe and can be taken along with the
traditional medicines for the treatment of Multiple Myeloma.
Some of the commonly indicated medicines for Multiple
Myeloma are Carcinosin, Thuja, Phosphorus, Radium bromatum,
etc. depending on the indications which are based on a
multi-factorial constitutional guidelines.